Erbil Yeşim, Kapran Yersu, Işsever Halim, Barbaros Umut, Adalet Işik, Dizdaroğlu Ferhunde, Bozbora Alp, Ozarmağan Selçuk, Tezelman Serdar
Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Am J Surg. 2008 Jan;195(1):34-9. doi: 10.1016/j.amjsurg.2007.01.040.
Although the sensitivity of sestamibi scanning (MIBI) is high in patients with solitary parathyroid adenomas, negative sestamibi scan results are inevitable. The exact mechanism of visualization of abnormal and hyperfunctioning parathyroid tissue is not yet clear. The aims of this clinical study were (1) to evaluate positive and negative sestamibi scan results with regard to adenoma weight and oxyphil cell content and (2) to compare the effects of adenoma weight and oxyphil cell content on the results of sestamibi scanning.
The patients were divided in 2 groups according to their sestamibi scan results. Group 1 consisted of 27 patients with positive sestamibi scan results, and group 2 consisted of 20 patients with negative sestamibi scan results. Parathyroid adenoma weight and oxyphil cell content were determined in all patients.
The weight and oxyphil cell content of the parathyroid adenomas in the patients of group 1 were significantly higher than those in the patients of group 2 (P = .001). An adenoma weight >600 mg and an oxyphil cell content >20% increased the rate of obtaining a positive sestamibi scan result 10- and 4-fold, respectively.
Both adenoma weight and oxyphil cell content were found to significantly correlate with positive sestamibi scan results. In patients with high-weight adenomas, adenoma weight was the most significant factor in obtaining positive MIBI scan results, whereas in patients with low adenoma weights, high oxyphil cell content was the most significant factor in obtaining positive MIBI scan results.
虽然 sestamibi 扫描(MIBI)对孤立性甲状旁腺腺瘤患者的敏感性较高,但 sestamibi 扫描结果为阴性的情况仍不可避免。甲状旁腺组织异常及功能亢进的可视化的确切机制尚不清楚。本临床研究的目的是:(1)评估 sestamibi 扫描结果阳性和阴性与腺瘤重量及嗜酸性细胞含量的关系;(2)比较腺瘤重量和嗜酸性细胞含量对 sestamibi 扫描结果的影响。
根据 sestamibi 扫描结果将患者分为两组。第 1 组由 27 例 sestamibi 扫描结果阳性的患者组成,第 2 组由 20 例 sestamibi 扫描结果阴性的患者组成。测定了所有患者的甲状旁腺腺瘤重量和嗜酸性细胞含量。
第 1 组患者甲状旁腺腺瘤的重量和嗜酸性细胞含量显著高于第 2 组患者(P = 0.001)。腺瘤重量>600 mg 和嗜酸性细胞含量>20%时,sestamibi 扫描结果为阳性的发生率分别增加 10 倍和 4 倍。
发现腺瘤重量和嗜酸性细胞含量均与 sestamibi 扫描结果阳性显著相关。在腺瘤重量高的患者中,腺瘤重量是获得 MIBI 扫描阳性结果的最主要因素,而在腺瘤重量低的患者中,嗜酸性细胞含量高是获得 MIBI 扫描阳性结果的最主要因素。